NYU’s Tsien to discuss brain plasticity at next Discovery Lecture
Mar. 29, 2021—Richard Tsien, PhD, director of the Neuroscience Institute at NYU Langone Medical Center, will deliver the next web-based Discovery Lecture.
Microscopic spines connect worm neurons
Oct. 17, 2019—Worm neurons have microscopic “spines” — where nerve-to-nerve communication happens — that share features with mammalian neurons, supporting the use of worms to study spine genetics and biology.
The Science of Mindfulness — What Do We Really Know and Where Do We Go?
Oct. 2, 2019—Rapid advancements in technology allows us to more accurately understand how mindfulness impacts, or changes, the brain, which is contributing to what we know. David Vago, PhD, explains.
Data science training program lands AAMC education award
Sep. 12, 2019—A course that provides biomedical scientists-in-training at Vanderbilt University School of Medicine with the essentials of data science has won second place in the 2019 Innovations in Research and Research Education Award program sponsored by the American Association of Medical Colleges (AAMC).
Lisa Monteggia to lead Vanderbilt Brain Institute
Mar. 12, 2018—Leading neuroscientist Lisa Monteggia has been named the Barlow Family Director of the Vanderbilt Brain Institute, Provost and Vice Chancellor for Academic Affairs Susan R. Wente announced today.
Research participants needed for neurofibromatosis study focused on reading difficulties
Mar. 1, 2018—The Vanderbilt Education and Brain Sciences Research Lab is seeking participants age 8 to 20 for a research study focusing on reading difficulties and neurofibromatosis.
Vanderbilt signs licensing, research agreements to develop new approach to schizophrenia treatment
Jan. 8, 2018—Under the terms of the licensing agreement, Lundbeck has exclusively licensed rights to compounds developed at Vanderbilt that act on a receptor in the brain that has been implicated in schizophrenia.
Goal of new tissue-chip research is to assess efficacy of novel epilepsy drugs
Sep. 20, 2017—An interdisciplinary team of Vanderbilt University researchers has received a two-year, $2-million federal grant to develop an “organ-on-chip” model for two genetic forms of epilepsy.
Vanderbilt begins Phase 1 trials of new Alzheimer’s drug
Aug. 7, 2017—Developed at Vanderbilt, VU319 is designed to precisely target a specific neuron receptor associated with cognitive function while avoiding potentially dangerous side effects.
Research that ruled in 2016: Readers’ favorite stories
Dec. 16, 2016—Artificial kidneys, gay-straight alliances and junkyard batteries captured readers' attention in 2016.
Blood-brain barrier on a chip sheds new light on “silent killer”
Dec. 6, 2016—A new microfluidic device containing human cells that faithfully mimics the behavior of the blood-brain barrier is providing new insights into brain inflammation, the silent killer.
Bioluminescent sensor causes brain cells to glow in the dark
Oct. 27, 2016—A team of Vanderbilt scientists have genetically modified luciferase, the enzyme that produces bioluminescence, so that it acts as an optical sensor that records activity in brain cells.